{"disease":{"id":"anthracycline","name":"anthracycline"},"drugs":{"marketed":[{"drug_id":"razoxane","indication_name":"Extravasation Injury from Anthracycline Injection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Razoxin","generic_name":"RAZOXANE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Razoxin works by chelating iron and preventing the formation of free radicals that damage heart tissue."},{"drug_id":"dexrazoxane","indication_name":"Extravasation Injury from Anthracycline Injection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zinecard","generic_name":"DEXRAZOXANE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"DNA topoisomerase 2-alpha","drug_class":"Cytoprotective Agent","quality_score":10,"revenue":null,"mechanism":"Zinecard works by binding to metal ions and preventing them from causing damage to DNA during anthracycline treatment."},{"drug_id":"zinecard","indication_name":"Extravasation Injury from Anthracycline Injection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zinecard","company_name":"M.D. Anderson Cancer Center","drug_phase":"phase_1","molecular_target":"DNA topoisomerase 2-beta, DNA topoisomerase 2-alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07254221","title":"Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Shiraz University of Medical Sciences","has_results":false},{"nct_id":"NCT06955702","title":"Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Salamanca","has_results":false},{"nct_id":"NCT06888505","title":"Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Hawler Medical University","has_results":false},{"nct_id":"NCT03934905","title":"Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Texas Tech University Health Sciences Center","has_results":false},{"nct_id":"NCT03850171","title":"Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":57,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT07426913","title":"Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT02076620","title":"L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Philogen S.p.A.","has_results":false},{"nct_id":"NCT06898320","title":"Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients","phase":"","overall_status":"RECRUITING","enrollment_count":22,"lead_sponsor_name":"IRCCS Burlo Garofolo","has_results":false},{"nct_id":"NCT07442578","title":"Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT03776149","title":"Cardiovascular Function in Cancer Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Kansas State University","has_results":false},{"nct_id":"NCT04095689","title":"Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":true},{"nct_id":"NCT04805346","title":"Remote Ischemic Conditioning in Oncology","phase":"NA","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}